NeuroConX brings together researchers, business leaders, clinical investigators and investment professionals to discuss the latest therapeutic approaches in the treatment of neurodegenerative diseases.
NeuroConX 2018 NeuroConX 2018 Program Highlights:
In the upcoming NeuroConX 2018 conference, “Mind Your Gut: The Role of the Gut Microbiome in Brain Health and Disease”, leading experts will discuss the latest scientific findings around microbiome effects in various brain disorders, including Parkinson’s disease, Alzheimer’s disease, ALS, autism, schizophrenia, and depression. Industry leaders will discuss ways in which innovators are harnessing the human microbiome and advancing novel therapeutics and diagnostics.
The human microbiota consists of the 10-100 trillion symbiotic microbial cells harbored by each person, primarily bacteria in the gut. Emerging evidence has demonstrated that intestinal homeostasis and the microbiome play essential roles in neurodegenerative diseases, such as Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), Huntington’s disease, and dementia, as well as neuropsychiatric conditions, such as depression and schizophrenia, and neurodevelopmental conditions, such as autism. The gut-brain axis involves a bidirectional signaling system that gives the gut influence over the brain through multiple processes, affecting immune responses, antioxidant processes, metabolic activity, and neuroplasticity.
The Symposium will feature a One-to-One Business Partnering Program. Online scheduling will be available to all registrants for business-to-business and business-to-academia meetings. Let this symposium move your commercialization strategy forward!
The Prince Edward Island BioAlliance is the location of choice for companies engaged in the research, development & commercialization of bioactives-based products for human, animal, and fish health and nutrition. Since 2005, the PEI Bioscience Cluster has more than tripled in size, with remarkable growth in business revenues and employment, and a marked increase in private and public-sector investments in our companies. PEI is home to over 50 bio-based companies, with $240 million in private sector revenues, and more than 1,575 people employed in the sector. PEI is home to the Emergence Bioscience Business Incubator – a national program supporting startup and scale-up companies from across Canada and beyond and to Natural Products Canada Inc. – one of Canada’s Centres of Excellence for the Commercialization and Research of natural products. Visit http://www.peibioalliance.com for more details about our companies, our programs, and our services.
Neurodyn is a biotechnology company utilizing a portfolio approach to identify, validate and develop bioactives for the early treatment of neurological diseases. Neurodyn’s business model is to maintain a dynamic portfolio of drug candidates focusing on joint ventures, out-licensing and partnering once each drug candidate that moves through the pipeline has reached a value-inflection point. For more information on Neurodyn, link here.
Venue: Prince Edward Island Convention Centre, 4 Queen Street, Charlottetown, Prince Edward Island. Delta Prince Edward Hotel is connected to the Convention Centre and is offering a discount rate to conference attendees.